Draper Hosts Australian Government Officials and Researchers to Discuss Diagnostic Technology

CAMBRIDGE, MA—Medical conditions ranging from breast cancer to post traumatic stress disorder could be diagnosed much more quickly by using magnetic resonance spectroscopy (MRS)—a type of MRI that measures the chemical content of tissues and organs—according to researchers. Given the promising potential for MRS as a diagnostic technology, the medical community is eager to explore various applications. To support this effort, Draper recently hosted a meeting with Premier Annastacia Palaszczuk, of Queensland, Australia, and a team from Harvard University, the Innovation and Translation Centre at Brisbane’s Translational Research Institute (TRI), Siemens Healthineers and Queensland University of Technology to discuss MRS and artificial intelligence during a recent Australian trade mission to Draper’s offices in Cambridge.

L-R Dr. Dorin Comaniciu (Siemens Healthineers), Tara Clark (Vice President of Commercial at Draper), Prof. Carolyn Mountford (CEO at TRI), Prof. Herb Kressel (Professor of Radiology at Harvard Medical School and retired Editor ‘Radiology’), Premier Annastacia Palaszczuk, Dr. Margaret Sheil (Queensland University of Technology) and Dr. John Irvine (Chief Scientist for Data Analytics, Draper). (Credit: TRI).
L-R Dr. Dorin Comaniciu (Siemens Healthineers), Tara Clark (Vice President of Commercial at Draper), Prof. Carolyn Mountford (CEO at TRI), Prof. Herb Kressel (Professor of Radiology at Harvard Medical School and retired Editor ‘Radiology’), Premier Annastacia Palaszczuk, Dr. Margaret Sheil (Queensland University of Technology) and Dr. John Irvine (Chief Scientist for Data Analytics, Draper). (Credit: TRI).